CLEC1B and neoplasm: More studies on PDPN-positive tumor cells and tumor/metastasis models containing patient-derived models, such as searching for the downstream pathways of PDPN leading to tumor metastasis, are warranted to provide insights into the development of novel therapies targeting the interaction of PDPN and CLEC-2.